| Clinical Study "Common" Name (formal title) | Number of enrollees | Funding source (pharmaceutical company/National Institutes of Health [NIH]) | Year complete | Primary publication | Full study treatment protocol/patient disposition |
|---|---|---|---|---|---|
|
MUST (Randomized Comparison of Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Implant for Intermediate, Posterior and Panuveitis: The Multicenter Uveitis Steroid Treatment Trial) |
225 |
National Eye Institute (NEI)/ National Institutes of Health (NIH). Additional support from Research to Prevent Blindness and the Paul and Evanina Mackall Foundation. |
2010 |
The Multicenter Uveitis Steroid Treatment (MUST) Research Group, Kempen JH, Atlaweel MM, et al. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: The Multicenter Uveitis Steroid Treatment Trial. Ophthalmology. 2011;118:1916-1926. https://www.aaojournal.org/article/S0161-6420(11)00681-6/fulltext |
|